Current Price Action and Market Context
As of 29 June 2026, Artemis Medicare Services Ltd closed at ₹261.05, down 1.66% from the previous close of ₹265.45. The stock traded within a range of ₹259.55 to ₹265.65 during the day, remaining below its 52-week high of ₹297.70 but comfortably above the 52-week low of ₹202.85. This price action suggests some near-term profit-taking or consolidation after recent gains.
Comparatively, the stock has outperformed the Sensex over longer horizons, delivering a 5.69% return over the past year against the Sensex’s decline of 6.83%. Over three and five years, Artemis Medicare has significantly outpaced the benchmark with returns of 138.47% and 764.69% respectively, underscoring its strong growth trajectory within the hospital sector.
Technical Trend Evolution
The technical trend for Artemis Medicare has shifted from bullish to mildly bullish, signalling a moderation in upward momentum. This nuanced change reflects a market that is still positive on the stock but with increased caution. The daily moving averages remain bullish, indicating that short-term price momentum is still supportive of higher levels. However, weekly and monthly indicators present a more mixed picture.
MACD and Momentum Oscillators
The Moving Average Convergence Divergence (MACD) indicator shows a bullish signal on the weekly chart, suggesting that momentum remains positive in the near term. Conversely, the monthly MACD is mildly bearish, indicating that longer-term momentum may be weakening or entering a consolidation phase. This divergence between weekly and monthly MACD readings highlights the importance of monitoring multiple timeframes for a comprehensive view.
The Know Sure Thing (KST) indicator aligns with this mixed momentum, showing a bullish stance on the weekly timeframe but mildly bearish on the monthly. This further emphasises the current technical uncertainty, with short-term momentum favouring buyers while longer-term momentum signals caution.
Relative Strength Index and Bollinger Bands
The Relative Strength Index (RSI) currently offers no clear signal on either the weekly or monthly charts, suggesting that the stock is neither overbought nor oversold. This neutral RSI reading supports the view of a stock in consolidation rather than trending strongly in either direction.
Bollinger Bands on the weekly chart remain bullish, indicating that price volatility is contained within an upward channel. However, the monthly Bollinger Bands show a sideways pattern, reinforcing the notion of a longer-term pause or range-bound movement.
Perfect timing to enter! This Small Cap from IT - Software just turned profitable with growth momentum clearly building up. Get in before the broader market notices!
- - New profitability achieved
- - Growth momentum building
- - Under-the-radar entry
Volume and On-Balance Volume (OBV) Analysis
On-Balance Volume (OBV) readings on the weekly chart are mildly bullish, indicating that buying volume is slightly outweighing selling pressure in the short term. However, the monthly OBV shows no clear trend, suggesting that longer-term accumulation or distribution is uncertain. This volume pattern aligns with the mixed momentum signals and points to a cautious market stance.
Dow Theory and Moving Averages
According to Dow Theory, the weekly trend is mildly bullish, supporting the notion of a positive near-term outlook. The monthly Dow Theory reading, however, indicates no clear trend, reinforcing the idea of a longer-term pause or consolidation phase. Daily moving averages remain bullish, which is a positive sign for traders looking for short-term entry points.
Mojo Score and Rating Upgrade
MarketsMOJO has upgraded Artemis Medicare Services Ltd’s Mojo Grade from Hold to Buy as of 8 June 2026, reflecting improved technical and fundamental outlooks. The stock’s Mojo Score stands at a robust 71.0, signalling favourable conditions for investors. This upgrade is consistent with the technical indicators showing a shift towards mild bullishness, despite some mixed signals on longer timeframes.
Investment Implications and Outlook
Investors should note that while Artemis Medicare Services Ltd exhibits strong long-term returns and a positive short-term technical setup, the mixed monthly indicators warrant a cautious approach. The stock’s current price near ₹261.05 is below its recent highs, offering a potential entry point for those seeking exposure to the hospital sector’s growth story. However, monitoring the monthly MACD and KST for signs of sustained momentum will be crucial to confirm a longer-term uptrend.
Thinking about Artemis Medicare Services Ltd? Our real-time Verdict report breaks down everything – from financial health and peer comparison to technical signals and fair valuation for this small-cap stock!
- - Real-time Verdict available
- - Financial health breakdown
- - Fair valuation calculated
Comparative Performance and Sector Context
Artemis Medicare’s performance relative to the Sensex highlights its resilience and growth potential. While the Sensex has declined by 9.53% year-to-date, Artemis has only fallen 3.67%, demonstrating relative strength. Over the past five years, the stock’s staggering 764.69% return dwarfs the Sensex’s 45.68%, underscoring its status as a high-growth small-cap within the hospital sector.
Given the hospital sector’s increasing importance amid evolving healthcare demands, Artemis Medicare’s technical and fundamental profile positions it well for investors seeking exposure to this space. However, the current mildly bullish technical trend advises a measured approach, balancing optimism with vigilance for potential volatility.
Summary of Technical Indicators
To recap, the key technical indicators for Artemis Medicare Services Ltd as of late June 2026 are:
- MACD: Weekly bullish, monthly mildly bearish
- RSI: Neutral on both weekly and monthly
- Bollinger Bands: Weekly bullish, monthly sideways
- Moving Averages: Daily bullish
- KST: Weekly bullish, monthly mildly bearish
- Dow Theory: Weekly mildly bullish, monthly no trend
- OBV: Weekly mildly bullish, monthly no trend
This blend of signals suggests that while short-term momentum remains positive, longer-term trends require close monitoring for confirmation of sustained strength.
Conclusion
Artemis Medicare Services Ltd’s technical momentum shift to mildly bullish reflects a stock at a crossroads, balancing strong short-term momentum against cautious longer-term signals. The recent upgrade to a Buy rating by MarketsMOJO and a solid Mojo Score of 71.0 support a constructive outlook, particularly for investors with a medium to long-term horizon. However, the mixed monthly indicators counsel prudence, making it essential to track evolving technical signals closely before committing significant capital.
Overall, Artemis Medicare remains a compelling small-cap opportunity within the hospital sector, combining robust historical returns with a cautiously optimistic technical profile as it navigates current market dynamics.
Only Rs. 9,999 - Get MojoOne + Stock of the Week for 1 Year Start at 33% Off →
